Title 21 of the Code of Federal Regulations
GPTKB entity
Statements (40)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:United_States_federal_law
|
| gptkbp:abbreviation |
21 CFR
|
| gptkbp:availableOn |
ecfr.gov
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:enforcedBy |
gptkb:Department_of_Health_and_Human_Services
gptkb:Drug_Enforcement_Administration gptkb:Food_and_Drug_Administration |
| gptkbp:firstPublished |
1938
|
| gptkbp:governs |
animal drugs
biologics color additives cosmetics dietary supplements food additives infant formula medical devices over-the-counter drugs prescription drugs tobacco products veterinary products controlled substances |
| gptkbp:hasPart |
Part 314 - Applications for FDA Approval to Market a New Drug
Part 1 - General Enforcement Regulations Part 1000 - Radiological Health Part 1300 - Controlled Substances Part 312 - Investigational New Drug Application Part 600 - Biological Products Part 800 - Medical Devices Part 210 - Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs |
| https://www.w3.org/2000/01/rdf-schema#label |
Title 21 of the Code of Federal Regulations
|
| gptkbp:language |
English
|
| gptkbp:legalCitation |
21 CFR
|
| gptkbp:publishedBy |
gptkb:Office_of_the_Federal_Register
|
| gptkbp:regulates |
food and drugs
|
| gptkbp:updated |
annually
|
| gptkbp:bfsParent |
gptkb:21_CFR_Part_312
gptkb:21_CFR_50 gptkb:21_CFR_Part_58 gptkb:21_CFR_133.165 |
| gptkbp:bfsLayer |
7
|